Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

11.96 +0.51 (+4.41%)
Streaming Delayed Price Updated: 10:02 AM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
News headline image
Continued Uncertainty ↗
Fear of another Fukushima yesterday late in the market day led to a rush out of energy-related shares, which included many without any nuclear risk at all. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
News headline image
Recap: NovoCure Q1 Earnings ↗
Shares of NovoCure (NASDAQ:NVCR) fell 2.7% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 200.00% year over... 
Via Benzinga
News headline image
Dreary Day ↗
Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold. 
Via Talk Markets
News headline image
Unheeding Markets ↗
Today oil prices rose over $70. 
Via Talk Markets
News headline image
Wednesday News And Catch-Up ↗
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA. 
Via Talk Markets
Topics Stocks
News headline image
Juvenile Investing Mob ↗
Tech stocks did well in Europe but not in the US. The data are unconvincing. 
Via Talk Markets
News headline image
3 Unstoppable Stocks That Can Leave Dogecoin in the Dust ↗
These fundamentally strong stocks are much better bets than the over-hyped Dogecoin. 
Via The Motley Fool
News headline image
2 Innovative Growth Stocks to Buy for June ↗
Got cash? Consider these high-flying growth stocks. 
Via The Motley Fool
News headline image
Sterling At Five-Year High ↗
Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro. 
Via Talk Markets
News headline image
Novocure Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate Tumor Treating Fields Together with GammaTile® Therapy in Recurrent Glioblastoma
From Novocure
Via Business Wire
News headline image
Better Mood Day ↗
The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion. 
Via Talk Markets
News headline image
May Or May Not Happen ↗
Another day, another drop. 
Via Talk Markets
News headline image
Novocure Surges As FDA Allows A Six Months Shorter Lung Cancer Study ↗
Novocure said Tuesday it could have the results of a pivotal lung cancer study six months sooner than expected, leading NVCR stock to pop. 
Via Investor's Business Daily
News headline image
Novocure Gets FDA Approval For Reducing Sample Size For Late-Stage Pivotal LUNAR Lung Cancer Study ↗
The FDA has approved Novocure Ltd's (NASDAQ: NVCR) Investigational Device Exemption (IDE) supplement, reducing the enrollment requirement for its LUNAR Phase 3... 
Via Benzinga
News headline image
Novocure Announces FDA Approval of IDE Supplement for Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
From Novocure
Via Business Wire
News headline image
Friday Of The Heavy Week ↗
There is nothing like a pending weekend to push Wall Street into recuperation and this worked today 
Via Talk Markets
News headline image
Could Novocure Be a Millionaire-Maker Stock? ↗
It's a good stock, but it might struggle to make you rich overnight. 
Via The Motley Fool
News headline image
Heavy Global Erosion ↗
It is an everything-down day. Even the news is down because commenters are being careful. 
Via Talk Markets
News headline image
Gold Up Four Days In A Row ↗
The dollar is at a nearly 3 month low. 
Via Talk Markets
News headline image
Calm Markets Day ↗
Despite seriously disappointing April jobless numbers, markets are gaining all the same. 
Via Talk Markets
News headline image
Finns and Danes ↗
Stock markets are still uncertain whether to rise or fall after the Tuesday debacle. 
Via Talk Markets
News headline image
Cramer Weighs In On Penn National Gaming, Palantir And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said he happens to like Penn National Gaming, Inc (NASDAQ: PENN) very much and it deserves to trade higher. Alcoa (... 
Via Benzinga
News headline image
Unusually Heavy Friday ↗
Today is a heavy news day, which is unusual for a Friday. We start with the largest company's lamentable report, follow with another confusing result, then a hopeful drug company report, and finish... 
Via Talk Markets
News headline image
Is Novocure Stock Overvalued? ↗
Did the market overreact to the company's good news? 
Via The Motley Fool
News headline image
Stock Market Rally Navigates Earnings From Apple, Tesla, Google, Facebook, Microsoft, Amazon ↗
The stock market rally navigated earnings from Apple, Tesla and the other "big six" market cap companies. Many breakouts, but not all succeeded. 
Via Investor's Business Daily
News headline image
Another Heavy News Day ↗
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week. 
Via Talk Markets
News headline image
NovoCure (NVCR) Q1 2021 Earnings Call Transcript ↗
NVCR earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
News headline image
Novocure Reports Surprise Loss As Revenue Falls Short ↗
Novocure reported a surprise loss as the cancer-fighting medtech missed on revenue. NVCR stock fell. 
Via Investor's Business Daily
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.